Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

Gold Standard Diagnostics Frankfurt GmbH

US

Last updated May 30, 2026

Part of Gold Standard Diagnostics Frankfurt GmbH

What Gold Standard Diagnostics Frankfurt GmbH makes

The company manufactures in vitro diagnostic enzyme immunoassay (EIA) kits for detecting immunoglobulin G (IgG) antibodies against specific pathogens, including Coxiella burnetii, Echinococcus species, Brucella species, Influenza A/B viruses, measles virus, Entamoeba histolytica, adenovirus, and various parasitic infections such as mumps, schistosomiasis, strongyloidiasis, toxocariasis, trichinellosis, and taeniasis. These kits are designed for laboratory use to aid in the serological diagnosis of infections caused by these agents.

The portfolio includes devices classified as Class I and Class II under regulatory frameworks, with listings in the FDA’s Unique Device Identifier (UDI) database. The manufacturer operates from the United States, adhering to applicable in vitro diagnostic device regulations

Written from this company's registered devices by an AI model, and not verified by a human reviewer.

Frequently asked questions

What types of medical devices does Gold Standard Diagnostics Frankfurt GmbH manufacture?

Gold Standard Diagnostics Frankfurt GmbH specializes in in vitro diagnostic (IVD) enzyme immunoassay (EIA) kits. These kits detect immunoglobulin G (IgG) antibodies against specific pathogens, such as bacteria, viruses, and parasites. Examples include tests for Coxiella burnetii (Q-Fever), Influenza A/B viruses, measles, Entamoeba histolytica, and parasitic infections like Strongyloides and Toxocara canis. The kits are designed for laboratory use to help diagnose infections caused by these agents.

Where is Gold Standard Diagnostics Frankfurt GmbH based?

The company is based in the United States. While the name includes 'Frankfurt,' this appears to be part of the company’s branding rather than its physical location. The manufacturer operates from within the U.S., where it develops and produces its IVD enzyme immunoassay kits.

Which regulatory registries list the devices manufactured by Gold Standard Diagnostics Frankfurt GmbH?

The devices produced by Gold Standard Diagnostics Frankfurt GmbH are listed in the FDA’s Unique Device Identifier (UDI) database. This registry helps track and identify medical devices authorized for use in the U.S., ensuring transparency and traceability for healthcare providers and regulators.

How are the devices manufactured by Gold Standard Diagnostics Frankfurt GmbH classified under regulatory frameworks?

The company’s devices fall into two primary regulatory classifications: Class I and Class II. Class I devices generally pose minimal risk and require less regulatory oversight, while Class II devices involve a moderate risk and may require specific controls to ensure safety and performance. The classification depends on factors like the device’s intended use and potential health impact, as determined by regulatory authorities.

What is the primary purpose of the enzyme immunoassay (EIA) kits produced by Gold Standard Diagnostics Frankfurt GmbH?

The EIA kits are designed for serological diagnosis in laboratory settings. They detect IgG antibodies in a patient’s blood, indicating prior exposure or infection by specific pathogens. For example, a kit for Coxiella burnetii IgG helps confirm Q-Fever infection, while a kit for Strongyloides detects parasitic infections. These tests aid clinicians in diagnosing infections and guiding treatment decisions.

AI-generated from registry data and not verified by a human reviewer.

Information

Country
US
Address
—
LinkedIn
—
Facebook
—
Phone
+1(888)977-4739
PRRC Contact
—
EUDAMED SRN
—
FDA FEI Number
—
DUNS Number
330328514

Catalogue (19)

DeviceModel / ReferenceRegistriesClassStatus
NovaLisa Mumps Virus IgG MUMG0340
FDA UDI
Class IActive
NovaLisa Schistosoma mansoni IgG SCHG0410
FDA UDI
Class IActive
NovaLisa Adenovirus IgG ADVG0010
FDA UDI
Class IActive
NovaLisa Strongyloides STRO0690
FDA UDI
Class IActive
NovaLisa Toxocara canis IgG TOCG0450
FDA UDI
Class IActive
NovaLisa Respiratory Syncytial Virus IgG RSVG0380
FDA UDI
Class IActive
NovaLisa Coxiella burnetii (Q-Fever) Phase 2 IgG COX2G060
FDA UDI
Class IActive
NovaLisa Trichinella spiralis IgG TRIG0480
FDA UDI
Class IActive
NovaLisa Taenia solium IgG TAEG0420
FDA UDI
Class IActive
NovaLisa Measles Virus IgG MEAG0330
FDA UDI
Class IActive
NovaLisa Brucella IgG BRUG0050
FDA UDI
Class IIActive
NovaLisa Entamoeba histolytica IgG ENTG0140
FDA UDI
Class IIActive
NovaLisa Coxiella burnetii (Q-Fever) Phase 1 IgG COX1G060
FDA UDI
Class IActive
NovaLisa Parainfluenza Virus 1, 2, 3 IgG PAIG0360
FDA UDI
Class IActive
NovaLisa Influenza Virus B IgG INFG0300
FDA UDI
Class IActive
NovaLisa Mycoplasma pneumoniae IgG MYCG0350
FDA UDI
Class IActive
NovaLisa Leptospira IgG LEPG0660
FDA UDI
Class IIActive
NovaLisa Influenza Virus A IgG INFG0290
FDA UDI
Class IActive
NovaLisa Echinococcus IgG ECHG0130
FDA UDI
Class IActive

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.